Cardinal Health, Inc. (CAH)

HEALTH CARE: HEALTH CARE SERVICES
SIC: WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

7000 CARDINAL PLACE DUBLIN, OH 43017

Cardinal Health, Inc. (Cardinal Health) is a global healthcare solutions company providing products and services to hospitals, physician offices and pharmacies. During the fiscal year ended June 30, 2010 (fiscal 2010), the Company operated in two segments: Pharmaceutical and Medical. The Pharmaceutical segment included the businesses that were previously within the Healthcare Supply Chain Services segment that distributed pharmaceutical, radiopharmaceutical and over-the-counter healthcare products, as well as the businesses previously within the All Other segment. The Medical segment included the remaining businesses within the Healthcare Supply Chain Services segment and certain surgical and exam gloves, surgical drapes and apparel and fluid management businesses that were previously within the Clinical and Medical Products segment.

Data based on most recent fiscal year report
Market Cap19.279 Billion Shares Outstanding314.6 Million Avg Volume4.081 Million
1-Yr BETA vs S&P TR Current Ratio1.34 Quick Ratio0.8
View SEC Filings from CAH instead.
Q4 2018 All Institutions Hedge Funds 1
To trade CAH now:
Filers who had this stock in their top 10: 5 2 (0.2%)
13F Filers holding this stock: 699 79 (7.83%)
Aggregate 13F shares on 12/31/2018: 261.68 Million 31.119 Million
Aggregate 13F shares on 09/30/2018: 265.343 Million 39.276 Million
Percent change: -1.38% -20.77%
Funds creating new positions: 126 25
Funds Adding to an existing position: 198 26
Funds closing out their position: 90 8
Funds reducing their position: 274 23
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CAH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DARDEN CALVIN

  • Director
0 2019-04-15 6

LOSH J MICHAEL

  • Director
0 2019-04-15 4

CASEY DONALD M JR. PRESIDENT & CEO

  • Officer
  • Director
128,131 2019-04-12 0

CRAWFORD VICTOR L.

  • Director
8,905 2019-04-11 2

RAISBECK DAVID W

  • Director
0 2019-04-05 0

KING DAVID P PRESIDENT & CEO

  • Officer
  • Director
355,484 2019-04-01 0

KENNY GREGORY B

  • Director
  • CHAIRMAN OF THE BOARD
42,566 2019-04-01 1

KILLEFER NANCY

  • Director
2,019 2019-04-01 1

CONRADES GEORGE H

  • Director
4,334 2019-04-01 0

CLARK R KERRY

  • Director
47,375 2019-04-01 0

NOTEBAERT RICHARD C

  • Director
0 2019-03-31 0

ANDERSON DAVID J

  • Director
0 2019-03-31 0

FRANCIS PHILIP L

  • Director
86,167 2019-03-28 0

GOMEZ JORGE M

  • Director
0 2019-03-27 3

JAIN VIVEK CHAIRMAN AND CEO

  • Officer
  • Director
69,995 2019-03-27 0

MAYER JESSICA L CHIEF LEGAL/COMPLIANCE OFFICER

  • Officer
31,031 2019-03-22 1

DOWNEY BRUCE

  • Director
28,234 2019-03-18 1

BARRETT GEORGE S

  • Director
4,794 2019-03-13 1

HENDERSON JEFFREY WILLIAM

  • Director
0 2019-03-12 0

JONES CLAYTON M

  • Director
18,778 2019-03-06 0

MORRISON PATRICIA

  • Director
26,359 2019-03-04 2

HALL PATRICIA HEMINGWAY

  • Director
0 2019-02-28 1

FINN JOHN F

  • Director
29,342 2019-02-26 0

JOHRI AKHIL EXECUTIVE VP AND CFO

  • Officer
60,182 2019-02-20 1

COX CARRIE SMITH

8,000 2019-02-19 1

GIACOMIN JON L CEO, MEDICAL SEGMENT

  • Officer
68,241 2019-02-15 3

RICE BRIAN S CHIEF INFORMATION OFFICER

  • Officer
12,617 2019-02-15 2

WALTER ROBERT D

  • Director
0 2019-02-11 0

FONG IVAN K SR. VP, LEGAL & GEN. COUNSEL

  • Officer
27,057 2019-02-05 0

ARNOLD COLLEEN F.

  • Director
4,513 2019-01-31 1

KAUFMANN MICHAEL C

  • Director
0 2019-01-29 3

HOLCOMB MICHELE EVP - STRATEGY & CORP. DEV.

  • Officer
17,356 2019-01-16 2

LAWS STUART G SVP & CHIEF ACCOUNTING OFFICER

  • Officer
6,260 2018-12-03 3

MORFORD CRAIG S CHIEF LEGAL/COMPLIANCE OFFICER

  • Officer
126,301 2018-12-03 3

SNOW OLA M CHIEF HUMAN RESOURCES OFFICER

  • Officer
15,109 2018-10-15 2

KIMMET PAMELA O. CHIEF HUMAN RESOURCES OFFICER

  • Officer
22,612 2018-08-15 2

OHALLERAN MICHAEL D

  • Director
15,586 2018-08-01 0

FITZGERALD MEGHAN

  • Director
0 2018-06-14 0

SCHLOTTERBECK DAVID L

  • Director
0 2017-05-22 0

WATKINS CAROLE S CHIEF HR OFFICER

  • Officer
33,994 2016-05-20 0

MCCOY JOHN B

  • Director
No longer subject to file 2016-04-29 0

STEPHEN FALK T EVP, GEN. COUNSEL & CORP. SEC.

  • Officer
32,455 2015-11-30 0

BLAKE MARK R EVP - STRATEGY & CORP. DEV.

  • Officer
20,409 2014-11-07 0

BRITT GLENN

  • Director
177,571 2014-06-06 0

SPAULDING JEAN G

  • Director
No longer subject to file 2013-11-06 0

LYNCH MICHAEL A CEO, MEDICAL SEGMENT

  • Officer
89,204 2012-02-27 0

WALTER MATTHEW D

  • Director
No longer subject to file 2010-12-08 0

MONGAN JAMES J MD

  • Director
7,150 2010-11-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

DARDEN CALVIN - Director

2019-04-15 A 122 $46.79 a 6,348 0.00 direct

LOSH J MICHAEL - Director

2019-04-15 A 694 $46.79 a 896 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments